Managing Common Warts in Children Under 18 Years
Common warts in paediatric patients present a distinct clinical challenge. In children under 18 years of age, particularly those with recalcitrant or multiple lesions, a specific evidence-based approach is warranted to achieve clearance.
This protocol applies to patients under 18 years of age presenting with common warts — a subgroup for which targeted treatment guidance exists, especially when warts are multiple or have not responded to initial measures.
The recommended approach involves an intralesional immunotherapy strategy. The full regimen — including agent selection, administration schedule, and management of non-response — is detailed in the complete protocol.
The primary target is complete clearance of warts at 4 weeks, with the criterion for cure also requiring no recurrence beyond the initial assessment period.
How should children (under the age of 18) with cutaneous warts be treated?
Intralesional Candida antigen immunotherapy is suggested for children with recalcitrant and multiple warts.
The clinical criteria for cure of warts are complete clearance of lesions at 4 weeks and no recurrence for at least 6 months.
View source ↗